research Phase I Study of the Hedgehog Pathway Inhibitor IPI-926 in Adult Patients with Solid Tumors
The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.
New York, NY, United States
Glasgow, United Kingdom
Incomplete name
Vaughan, ON, Canada
London, United Kingdom
Mumbai, Maharashtra, India
Auckland, New Zealand


